LitCovid-sentences  

PMC:7799377 / 126-1691 JSONTXT 3 Projects

Annnotations TAB TSV DIC JSON TextAE

Id Subject Object Predicate Lexical cue
T7 0-8 Sentence denotes ABSTRACT
T8 9-96 Sentence denotes Neurological manifestations are increasingly reported in a subset of COVID-19 patients.
T9 97-298 Sentence denotes Previous infections related to coronaviruses, namely Severe Acute Respiratory Syndrome (SARS) and Middle Eastern Respiratory Syndrome (MERS) also appeared to have neurological effects on some patients.
T10 299-524 Sentence denotes The viruses associated with COVID-19 like that of SARS enters the body via the ACE-2 receptors in the central nervous system, which causes the body to balance an immune response against potential damage to nonrenewable cells.
T11 525-603 Sentence denotes A few rare cases of neurological sequelae of SARS and MERS have been reported.
T12 604-806 Sentence denotes A growing body of evidence is accumulating that COVID-19, particularly in severe cases, may have neurological consequences although respiratory symptoms nearly always develop prior to neurological ones.
T13 807-927 Sentence denotes Patients with preexisting neurological conditions may be at elevated risk for COVID-19-associated neurological symptoms.
T14 928-1140 Sentence denotes Neurological reports in COVID-19 patients have described encephalopathy, Guillain-Barré syndrome, myopathy, neuromuscular disorders, encephalitis, cephalgia, delirium, critical illness polyneuropathy, and others.
T15 1141-1284 Sentence denotes Treating neurological symptoms can pose clinical challenges as drugs that suppress immune response may be contraindicated in COVID-19 patients.
T16 1285-1393 Sentence denotes It is possible that in some COVID-19 patients, neurological symptoms are being overlooked or misinterpreted.
T17 1394-1565 Sentence denotes To date, neurological manifestations of COVID-19 have been described largely within the disease trajectory and the long-term effects of such manifestations remain unknown.